Navigation Links
CellHealth Institute Launches New Cell Health Formula

MONTCLAIR, N.J., May 1, 2013 /PRNewswire/ -- CellHealth™ Institute, a biotechnology company focused on cellular health, research and holistic lifestyle education, today launched its cell health formula, everycell™.



Developed by a team of cell health and aging experts, and in partnership with GMP manufacturers, everycell contains more than 90 essential phytonutrients, vitamins and minerals that the body needs to function optimally. Using natural ingredients including Fruitura™ and Aquamin™, the proprietary complexes of everycell deliver these nutrients to a person's cells, helping to create the ideal cellular environment to support a healthy lifestyle.

The everycell formula has seven unique complexes that support: cell regulation; free radical scavenging; DNA repair; telomere maintenance; stem cell maintenance; calorie restriction, digestion and absorption. These complexes were perfected over time by CellHealth Institute scientists to address the intricate infrastructure of cell health, including cell repair, aging, and replication, which directly affect the body's ability to function on a day-to-day basis.

"The trillions of cells that make up the human body determine the state of a person's health," said Dr. Vincent Giampapa, CellHealth Institute's chief medical officer. "Simply stated, when our cells are healthy, we are healthy. The everycell formula is specifically designed to take daily—morning and night—to provide the natural plant-derived complexes needed to help people work, play and rest at their optimal level. It's no longer simply about the vitamins and minerals, but about creating the cellular environment for those nutrients to be utilized most effectively."

The "awake" and "asleep" formulas are designed to take in the morning and evening each day to help optimize cell efficiency during the different parts of the day.

David Saloff, chief executive of CellHealth Institute, said, "We are committed to developing and delivering the highest quality products and services that will enable and empower people to live healthier lives for longer. We live in an era where we're increasingly affected by toxicity in the environment, our diets and lifestyles. But it's also an exciting era, where technological advancement and scientific research are giving us the tools to maintain and improve our health. And everycell is our gateway formula to improved cell health."

The everycell formula comes in packages of 120 tablets – 60 "awake" and 60 "asleep" -- and is available for purchase at for $79 per month as part of a continuity program.

For more information, or to purchase, visit

About CellHealth™ Institute

CellHealth Institute (CHI) is a biotechnology company focused on cellular health that integrates breakthrough products and services with holistic lifestyle education. CHI collaborates with top-tier research universities and publicly traded biotech companies to offer fully integrated personalized health programs paired with scientific biomarker evaluations, as well as medical-grade supplements, including everycell™, and advanced treatment through stem cell therapies. The organization is headquartered in New Jersey with an international regenerative medicine destination in Costa Rica set to open in 2014. CHI services and products allow people to take control of their own health at the most basic level – their cells.



SOURCE CellHealth Institute
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. CellHealth Institute Launches with Support from Influential Investors
2. Masaryk Memorial Cancer Institute Reduces Losses and Administrative Overhead With Ekahau RTLS
3. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
4. The Pharmabiotic Research Institute (PRI) is Preparing to Publish its First Works on the Therapeutic and Medicinal Potential of Probiotics
5. Michael A. Marletta Takes Office as New President of Scripps Research Institute
6. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
7. QIAGEN and Max Planck Institute for Infection Biology Collaborate to Develop Assay for Active TB Risk in Individuals With Latent Infection
8. DFH Pharma to Collaborate With National Cancer Institute to Develop Second-Generation HIV Maturation Inhibitor Drugs
9. Niels Bohr Institute gets top researcher from Harvard
10. Van Andel Research Institute Study Provides New Details of Fundamental Cellular Process
11. Lupus Research Institute Awards $3.6 Million for Novel Studies Driving Wide-Ranging New Science in Lupus
Post Your Comments:
(Date:11/25/2015)... BRUSSELS , November 25, 2015 ... in cat and human plaque and pave the way for ... health problems in cats     ... the most commonly diagnosed health problems in cats, yet relatively ... until now. Two collaborative studies have been conducted by researchers ...
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris ... that its business and prospects remain fundamentally strong ... Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation to ... completion following review of the final interim efficacy ... 2 Primary Endpoint in men with heavily pretreated ...
(Date:11/25/2015)... , November 25, 2015 ... Research Report is a professional and in-depth study ...      (Logo: ) , ... of the industry including definitions, classifications, applications and ... provided for the international markets including development trends, ...
(Date:11/24/2015)... ... 2015 , ... The United States Golf Association (USGA) today announced Dr. Bruce ... Presented annually since 1961, the USGA Green Section Award recognizes an individual’s distinguished service ... , Clarke, of Iselin, N.J., is an extension specialist of turfgrass pathology in the ...
Breaking Biology Technology:
(Date:11/10/2015)... 2015 About signature verification ... to identify and verify the identity of an ... the secure and accurate method of authentication and ... individual because each individual,s signature is highly unique. ... dynamic signature of an individual is compared and ...
(Date:11/9/2015)...  Synaptics Inc. (NASDAQ: SYNA ), the leading ... into the automotive market with a comprehensive and dedicated ... consumer electronics human interface innovation. Synaptics, industry-leading touch controllers, ... automotive industry and will be implemented in numerous locations ... , Japan , and ...
(Date:11/2/2015)... 2015  SRI International has been awarded a contract ... services to the National Cancer Institute (NCI) PREVENT Cancer ... expertise, modern testing and support facilities, and analytical instrumentation ... toxicology studies to evaluate potential cancer prevention drugs. ... Cancer Drug Development Program is an NCI-supported pipeline to ...
Breaking Biology News(10 mins):